Mersana Therapeutics, Inc.
MRSNDelisted Jan 6, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001442836
Mersana Therapeutics, Inc. was delisted on Jan 6, 2026; its insiders filed their last Form 4 on Jan 6, 2026; 51 institutions reported holding it in 13F filings for Q4 2025, worth $64.8M in total; no superinvestor held it.
Q2 2026 vs. Q1 2026
How the institutions holding Mersana Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 1 | 0 | −1 |
| Shares | 3 | 0 | −3 (−100.0%) |
| Value | $87 | $0 | −$87 (−100.0%) |
New holders (0)
Institutions that held Mersana Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
None.
Sold out (1)
Institutions that held Mersana Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| IFP Advisors, Inc | 3 | $87 |